<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJPed</journal-id><journal-title-group><journal-title>Open Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2160-8741</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojped.2022.122042</article-id><article-id pub-id-type="publisher-id">OJPed-117124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Tuberculosis in Children: Epidemio-Clinical Aspects in the Paediatric Department of the Gabriel Tour&#233; University Hospital Center
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adama</surname><given-names>Dembélé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoul</surname><given-names>Aziz Diakité</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Elmouloud Cissé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bassirou</surname><given-names>Diarra</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Belco</surname><given-names>Maïga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Issa</surname><given-names>Sanou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pierre</surname><given-names>Togo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoul</surname><given-names>Karim Doumbia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oumar</surname><given-names>Coulibaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Karamoko</surname><given-names>Sacko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djéneba</surname><given-names>Konaté</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hawa</surname><given-names>Diall</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lala</surname><given-names>Ndrainy Sidibé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bréhima</surname><given-names>Dégoga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatoumata</surname><given-names>Léonie Diakité</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guédiouma</surname><given-names>Dembélé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatoumata</surname><given-names>Dicko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mariam</surname><given-names>Sylla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boubacar</surname><given-names>Togo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Pediatrics, CHU Gabriel Touré, Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>Department of Paediatrics, University Teaching Hospital of Gabriel Touré, Bamako, Mali</addr-line></aff><pub-date pub-type="epub"><day>21</day><month>04</month><year>2022</year></pub-date><volume>12</volume><issue>02</issue><fpage>376</fpage><lpage>388</lpage><history><date date-type="received"><day>29,</day>	<month>March</month>	<year>2022</year></date><date date-type="rev-recd"><day>13,</day>	<month>May</month>	<year>2022</year>	</date><date date-type="accepted"><day>16,</day>	<month>May</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introd
  uction: 
  Globally, tuberculosis is the leading cause of death from a single infectious agent ahead of HIV/AIDS. Approximately 10 million people contracted TB in 2017, 10% of whom were children aged 0 - 15 years, or about 1 million with 250,000 deaths in 2016 (including children with HIV-associated T
  B). The signs of TB in children are not always specific and diagnosis remains difficult unlike in adults. According to a study conducted in 2011 in the paediatric department of the CHU-Gabriel Tour&#233;, only seventeen cases of all forms of tuberculosis were found, or approximately 0.2% of hospitalised children. The objective of our study was to investigate the epidemiological and clinical aspects of tuberculosis in children. <b>Materials and Method:</b> This was a prospective, cross-sectional and descriptive study that took place from 24 October 2017 to 23 October 2018, or 12 months in children aged 0-15 years. Data were collected from an individual medical record opened for each patient and an individual survey form established for each child. <b>Results:</b> During the study period, 40,434 children were consulted. Tuberculosis was suspected in 91 children, with a frequency of 0.22%. The age range of 1 to 4 years was 36.3% with a median age of 72 months. The sex ratio was 1.8. Chronic cough with 84.6% and malnutrition with 24.17% were the most frequent symptoms. Chest X-ray revealed bilateral pulmonary lesions in 52.7% and mediastinal adenopathy in 12.1%. TST was positive in 10.9% of patients, microscopy in 26.4%, Gene Xpert in 18.7%, and culture in 16.5%. The biological diagnosis of tuberculosis was retained in 48.4% of the patients, the pulmonary form represented 93.2%. The therapeutic regime (2RHZE/4RH) was used in 81.6% of cases and the evolution was favourable in 65.9% of patients. <b>Conclusion:</b> The diagnosis of tuberculosis in children remains difficult in our context. The clinical signs are not always specific, and further studies are needed to further elucidate this disease.
 
</p></abstract><kwd-group><kwd>Child</kwd><kwd> Clinic</kwd><kwd> Epidemiology</kwd><kwd> Gabriel Tour&#233; University Hospital Center</kwd><kwd> Tuberculosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Tuberculosis is an infectious disease caused by the bacillus of the Mycobacterium tuberculosis complex, also known as Bacillus Koch (BK) [<xref ref-type="bibr" rid="scirp.117124-ref1">1</xref>]. Pulmonary involvement is the most common site of infection and is the usual source of transmission. However, the bacillus can reach other organs, resulting in extra-pulmonary tuberculosis [<xref ref-type="bibr" rid="scirp.117124-ref2">2</xref>]. With the introduction of preventive measures such as the Calmette-Gu&#233;rin vaccine (BCG) in 1921 and the discovery of numerous effective antibiotics between 1944 and 1965, the eradication of tuberculosis was conceivable by the end of the 20<sup>th</sup> century. Unfortunately, the disease is still with us today [<xref ref-type="bibr" rid="scirp.117124-ref3">3</xref>]. Globally, TB is the leading cause of death from a single infectious agent, ahead of HIV/AIDS. Approximately 10 million people contracted TB in 2017, 10% of whom were children aged 0 - 15 years, or about 1 million with 250,000 deaths in 2016 (including children with HIV-associated TB). The number of children under five receiving preventive treatment was 292,182 in 2017, three times the number in 2015 (87,242) [<xref ref-type="bibr" rid="scirp.117124-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.117124-ref5">5</xref>]. In C&#244;te d’Ivoire, the number of cases in children was 1243 in 2013, representing 5.2% of new cases and 4.9% of all notified cases [<xref ref-type="bibr" rid="scirp.117124-ref6">6</xref>]. The “objective 90-90-90” was the new 2016-2020 plan for TB control. The idea is to diagnose 90% of people with TB in 90% of the most vulnerable populations and ensure 90% cures with treatment. If they are achieved, these objectives should make it possible to eradicate tuberculosis epidemics by 2035 according to the WHO [<xref ref-type="bibr" rid="scirp.117124-ref7">7</xref>]. A total of 6889 TB cases were notified in Mali in 2018, children aged 0 - 14 years were 301 cases, or 4% [<xref ref-type="bibr" rid="scirp.117124-ref8">8</xref>]. The signs of TB in children are not always specific and diagnosis remains difficult unlike in adults. Many cases go unnoticed in our services or are treated as severe pneumonia. According to a study carried out in 2011 in the paediatric department of the CHU-Gabriel Tour&#233;, only seventeen cases of all forms of tuberculosis were found, or approximately 0.2% of hospitalised children [<xref ref-type="bibr" rid="scirp.117124-ref9">9</xref>]. Thus, we initiated this study in order to evaluate the real incidence of this pathology in the pediatric department of the CHU-GT.</p></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1 Study Setting and Location</title><p>Our study took place in the emergency department of the paediatric department of the CHU-Gabriel Tour&#233; in Bamako. Located in the centre of the city, this department receives patients from all the communes of Bamako and those referred from other localities in Mali. Despite the existence of community health centres and referral health centres, attendance is still very high. It is composed of a neonatology service to which the URENI (Intensive Nutritional Recovery and Education Unit) is attached, a general paediatrics service, and a paediatric emergency service. The latter was created in 2010 as part of the department’s restructuring. It includes a reception hall which is also a triage room, two consultation rooms, an inpatient sector with 20 cots, and 6 beds with two rooms for infants and one room for older children.</p></sec><sec id="s2_2"><title>2.2. Type of Study and Inclusion Criteria</title><p>This was a prospective, cross-sectional, descriptive study that ran from 24 October 2017 to 23 October 2018, a period of 12 months. We included all children aged 0 to 15 years who consulted the paediatric department of the CHU Gabriel Tour&#233; for suspected tuberculosis, whether or not they were hospitalised. An individual numbered medical file and an individual survey form were opened for each patient to collect data. Patients were examined by a paediatrician, accompanied by a graduate student. A single sputum sample was taken by gastric tube (if age less than or equal to 5 years) or by spontaneous sputum (if age greater than 5 years). A direct microscopy, Xpert MTB/RIF, and BK culture were performed on all patients. Lymph node biopsy was performed on 4 patients. The diagnosis of pulmonary tuberculosis was based on bacteriological criteria in patients with positive bacilloscopy. In the absence of bacteriological confirmation, the diagnosis was based on a combination of clinical and radiological evidence. Patients undergoing treatment were followed up for 6 months in 3 rounds (1 month after inclusion, 3 months after inclusion, and 6 months after inclusion). The variables studied were those relating to the socio-demographic characteristics of the children: age, sex, and socio-economic level of the parents. Then, we studied variables related to clinical and paraclinical characteristics: vaccination status, immune status (HIV), history, signs of bacillary impregnation, clinical manifestations, radiological signs, tuberculin TST, sputum examination, lymph node biopsy. As well as the clinical forms, treatment, and evolution, data writing, entry, and analysis were performed with world 2013, SPSS (version 20.0), and Excel 2013. Informed consent was obtained from the parents or carers by signature after a detailed explanation of the study protocol before inclusion and strict respect for the children’s anonymity was guaranteed. We used some operational definitions, among others:</p><p>&#183; Suspected TB case: any child presenting with</p><p>—a cough equal to or greater than two weeks and haemoptysis and/or prolonged fever;</p><p>—a cough of two weeks or more with weight loss and/or fever;</p><p>—a cough and a history of tuberculosis infection;</p><p>—adenopathy and emaciation.</p><p>&#183; Microscopy positive pulmonary tuberculosis (MPT+): if</p><p>—a sputum smear is positive for Acid-Fast Bacilli (AFB), and/or culture, and/or the Gene Xpert is positive for Mycobacterium tuberculosis.</p><p>&#183; Microscopy-negative pulmonary tuberculosis (mPTB-): if</p><p>—a suspect patient in whom the sputum specimen has returned negative for BAAR on microscopy, but who has persistent clinical symptoms and radiographic abnormalities consistent with active pulmonary TB despite non-specific broad-spectrum antibiotic treatment and for whom full antituberculosis chemotherapy has been prescribed.</p><p>&#183; Confirmed tuberculosis: if</p><p>—a patient in whom Gene Xpert MTB/RIF, and/or direct examination, and/or culture has come back positive for Mycobacterium tuberculosis and/or there is the presence of epithelioid gigantocellular granuloma with caseous necrosis on the lymph node biopsy on pathology examination.</p><p>&#183; Cured: if</p><p>—a patient with negative sputum examination in the last months of treatment (5<sup>th</sup> and 6<sup>th</sup>).</p><p>&#183; Completed treatment: if</p><p>—a patient who has completed treatment within the treatment timeframe, but whose biological result is not known.</p><p>&#183; Treatment failure: if</p><p>—a patient with a positive sputum smear at the 5<sup>th</sup> month or more of treatment;</p><p>—a patient lost to follow-up;</p><p>—a patient diagnosed with no response to the appointment and not heard from for more than 2 months.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Over a period of 12 months (from 24 October 2017 to 23 October 2018), we were able to collect 91 suspected cases of tuberculosis meeting our inclusion criteria out of a total of 40,434 consultations, either a frequency of 0.22%. The 1- to 4-year-old age group was the most affected with 36.3% of cases. The median age was 72 months. There was a male predominance with a sex ratio of 1.8. The socioeconomic level of the parents was considered unfavourable for 47.3% of the patients (<xref ref-type="table" rid="table1">Table 1</xref>). The main reasons for consulting the parents were: cough, breathing difficulty, and anorexia (<xref ref-type="table" rid="table2">Table 2</xref>). Many patients (73.6%) had a correct vaccination status against Mycobacterium tuberculosis (<xref ref-type="table" rid="table2">Table 2</xref>). BCG scars were found in 75.8% of patients (<xref ref-type="table" rid="table2">Table 2</xref>). The notion of chronic cough in the family (11%), tuberculosis disease in the family (11%), and tuberculosis contagion (23.1%) were the family histories frequently mentioned (<xref ref-type="table" rid="table3">Table 3</xref>). Chronic cough (84.6%), followed by malnutrition (24.17%) and mediastinal adenopathy (12.08%) on physical examination were the predominant clinical signs (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of suspected cases by socio-economic data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Socio-economic data</th><th align="center" valign="middle" >Effective (n: 91)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Age in years</td></tr><tr><td align="center" valign="middle" >&lt;1</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.8</td></tr><tr><td align="center" valign="middle" >1 - 4</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >36.3</td></tr><tr><td align="center" valign="middle" >5 - 10</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >28.6</td></tr><tr><td align="center" valign="middle" >11 - 15</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >26.4</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Sex</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >64.8</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >35.2</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Parents socio-economic conditions</td></tr><tr><td align="center" valign="middle" >Favourable</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.7</td></tr><tr><td align="center" valign="middle" >Acceptable</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >Unfavourable</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >47.3</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Mode of admission</td></tr><tr><td align="center" valign="middle" >Brought in by parents</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >79.1</td></tr><tr><td align="center" valign="middle" >Referred</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >20.9</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of suspected cases according to interview data and follow-up booklet</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Data from the interview and follow-up booklet</th><th align="center" valign="middle" >Effective (n: 91)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Reasons for consultation</td></tr><tr><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >65.93</td></tr><tr><td align="center" valign="middle" >Dyspnea</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >19.78</td></tr><tr><td align="center" valign="middle" >Anorexia</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >18.68</td></tr><tr><td align="center" valign="middle" >Tuberculosis consultation</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.38</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.38</td></tr><tr><td align="center" valign="middle" >Asthenia</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >12.09</td></tr><tr><td align="center" valign="middle" >Adenopathy</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.79</td></tr><tr><td align="center" valign="middle" >Deterioration of general condition</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.79</td></tr><tr><td align="center" valign="middle" >Chest pain</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.49</td></tr><tr><td align="center" valign="middle" >Abdominal distension</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.30</td></tr><tr><td align="center" valign="middle" >Severe malnutrition</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.20</td></tr><tr><td align="center" valign="middle" >Impotence of the lower limbs</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.10</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Immunisation status according to the Expanded Programme on Immunisation (EPI)</td></tr><tr><td align="center" valign="middle" >Correctly vaccinated</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >73.6</td></tr><tr><td align="center" valign="middle" >Incorrectly vaccinated</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >24.2</td></tr><tr><td align="center" valign="middle" >No vaccination received</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Presence of BCG scar</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >75.8</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >24.2</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of suspected cases by history</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="3"  >Background</th><th align="center" valign="middle" >Effective (n: 91)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  rowspan="4"  >Family history of chronic cough</td><td align="center" valign="middle"  colspan="2"  >No</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >89</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Yes</td><td align="center" valign="middle" >Mother</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.4</td></tr><tr><td align="center" valign="middle" >Father</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.4</td></tr><tr><td align="center" valign="middle" >Other member</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Family history of documented TB disease</td><td align="center" valign="middle"  colspan="2"  >No</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >89</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Yes</td><td align="center" valign="middle" >Mother</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.4</td></tr><tr><td align="center" valign="middle" >Father</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Other member</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Concept of tuberculosis contagion</td><td align="center" valign="middle"  colspan="2"  >No</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >76.9</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Yes</td><td align="center" valign="middle" >Mother</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >12.1</td></tr><tr><td align="center" valign="middle" >Father</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle" >Other member</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.5</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of suspected cases according to clinical examination data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Clinical examination data</th><th align="center" valign="middle" >Effective (n: 91)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Interrogation: Signs of bacillary impregnation</td></tr><tr><td align="center" valign="middle" >Chronic cough</td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >84.62</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >75.82</td></tr><tr><td align="center" valign="middle" >Unexplained (prolonged) fever</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >74.73</td></tr><tr><td align="center" valign="middle" >Night sweats</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >63.74</td></tr><tr><td align="center" valign="middle" >Asthenia</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >56.04</td></tr><tr><td align="center" valign="middle" >Anorexia</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >52.75</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Physical examination</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Nutritional status</td></tr><tr><td align="center" valign="middle" >Good Nutritional status</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >75.82</td></tr><tr><td align="center" valign="middle" >Moderate malnutrition</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.79</td></tr><tr><td align="center" valign="middle" >Severe malnutrition</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.38</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Colouration of the integuments</td></tr><tr><td align="center" valign="middle" >Good colouration</td><td align="center" valign="middle" >63</td><td align="center" valign="middle" >69.23</td></tr><tr><td align="center" valign="middle" >Moderate pallor</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >26.37</td></tr><tr><td align="center" valign="middle" >Severe pallor</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.40</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Chest morphology</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >94.51</td></tr><tr><td align="center" valign="middle" >Deformity</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.49</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Signs of respiratory struggle</td></tr><tr><td align="center" valign="middle" >Absent</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >45.05</td></tr><tr><td align="center" valign="middle" >Severe</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6.59</td></tr><tr><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >28.57</td></tr><tr><td align="center" valign="middle" >Minimal</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >19.78</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Lung auscultation</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8.79</td></tr><tr><td align="center" valign="middle" >Pathological</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >91.21</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Abdominal examination</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >70.33</td></tr><tr><td align="center" valign="middle" >Distended</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >9.89</td></tr><tr><td align="center" valign="middle" >Organomegaly</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.38</td></tr><tr><td align="center" valign="middle" >Ascites</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.40</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Presence of adenopathy</td></tr><tr><td align="center" valign="middle" >Cervical</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >14.29</td></tr><tr><td align="center" valign="middle" >Axillary</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >5.49</td></tr><tr><td align="center" valign="middle" >Inguinal</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.30</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Osteoarticular examination</td></tr><tr><td align="center" valign="middle" >Pott’s disease</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.10</td></tr></tbody></table></table-wrap><p>TST was positive in 10.99% of patients (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Microscopy was positive in 24 patients (26.4%), Gene Xpert in 17 patients (18.7%) and culture in 15 patients (16.5%). Lymph node biopsy was performed in 4 patients (4.4%) and was positive in 3 patients (3.3%) (<xref ref-type="table" rid="table5">Table 5</xref>). At the end of the above investigations, 44 patients were confirmed positive for TB out of 91 suspected cases (<xref ref-type="fig" rid="fig2">Figure 2</xref>). TB/HIV co-infection was found in 32.3% of cases (<xref ref-type="table" rid="table6">Table 6</xref>). Of the 44 confirmed cases, pulmonary tuberculosis constituted 41 cases (93.18%), and extra-pulmonary forms represented 3 cases, including 1 bone case and 2 lymph node cases (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Four patients died before the outcome, 2 were lost to follow-up and 38 were put on treatment (86.4%). The treatment was oriented according to the 2RHZE/4RH regimen (2 months of treatment with Rifampicin + Isoniazid + Pyrazinamide + Ethambutol, followed by 4 months of treatment with Rifampicin + Isoniazid) in 81.6% of the cases (<xref ref-type="table" rid="table7">Table 7</xref>). The evolution was favourable in 65.9%.</p></sec><sec id="s4"><title>4. Discussion</title><p>During the study period, the paediatric department recorded 40,434 consultations. Tuberculosis was suspected in 91 patients (0.22%) of whom 44 (48.35%) were diagnosed. Morba A [<xref ref-type="bibr" rid="scirp.117124-ref9">9</xref>] in 2011, found 17 cases of tuberculosis in the same department among hospitalised patients. Ciss&#233; A [<xref ref-type="bibr" rid="scirp.117124-ref10">10</xref>] and Segbedji K et al. [<xref ref-type="bibr" rid="scirp.117124-ref11">11</xref>] found respectively 345 cases over 6 years and 74 cases over 4 years from retrospective and multicentre studies. Our high rate compared to that of Morba A [<xref ref-type="bibr" rid="scirp.117124-ref9">9</xref>] could be explained by the fact that his study was carried out only on hospitalized</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of suspected cases according to tests results</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Results of tests</th><th align="center" valign="middle"  colspan="2"  >Culture</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >N&#233;gative</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Microscopy</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >24 (26.4%)</td></tr><tr><td align="center" valign="middle" >N&#233;gative</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >67 (73.6%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Gene Xpert</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >17 (18.7%)</td></tr><tr><td align="center" valign="middle" >N&#233;gative</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >74 (81.3%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Lymph node biopsy (n: 4)</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >N&#233;gative</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Distribution of patients by TB/HIV co-infection</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Statut HIV</th><th align="center" valign="middle"  colspan="2"  >Tuberculosis</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >N&#233;gative</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >13 (46.4%)</td><td align="center" valign="middle" >15 (53.6%)</td><td align="center" valign="middle" >28 (100%)</td></tr><tr><td align="center" valign="middle" >N&#233;gative</td><td align="center" valign="middle" >31 (49.2%)</td><td align="center" valign="middle" >32 (50.8%)</td><td align="center" valign="middle" >63 (100%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >44 (48.4%)</td><td align="center" valign="middle" >47 (51.6%)</td><td align="center" valign="middle" >91 (100%)</td></tr></tbody></table></table-wrap><p>Odds ratio: OR (confidence interval: CI) = 0.89 (0.3667 - 2.1828); P = 0.8067.</p><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Distribution of patients by treatment received and outcome</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Treatment received and progress</th><th align="center" valign="middle" >Effective</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Treatment received (n: 38)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >2 RHZE/4 RH</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >81.6</td></tr><tr><td align="center" valign="middle" >2RHZ/4 HR</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >15.8</td></tr><tr><td align="center" valign="middle" >2 RHZE/10 HR</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >Evolution (n: 44)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Cured</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >65.9</td></tr><tr><td align="center" valign="middle" >Lost sight of</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle" >Failed</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.3</td></tr><tr><td align="center" valign="middle" >Died</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >18.2</td></tr></tbody></table></table-wrap><p>R = Rifampicin; H = Isoniazid; Z = Pyrazinamide; E = Ethambutol.</p><p>patients. However, the high figures of Ciss&#233; A [<xref ref-type="bibr" rid="scirp.117124-ref10">10</xref>] and Segbedji K et al. [<xref ref-type="bibr" rid="scirp.117124-ref11">11</xref>] compared to ours can be explained by the duration of their different studies. The 0- to-5-years (<xref ref-type="table" rid="table1">Table 1</xref>) age group was the most affected with 45.1% of cases. This result is similar to that of Morba A [<xref ref-type="bibr" rid="scirp.117124-ref9">9</xref>] who reported 47.1% in the same age group. However, Soumana A [<xref ref-type="bibr" rid="scirp.117124-ref12">12</xref>] reported a higher frequency than ours (65.5%). All these results confirm the data in the literature according to which children under 5 years of age are the most affected by tuberculosis infection. In addition, young age is also a factor increasing the risk of progression to TB disease. Boys were in the majority with 64.8% of cases, a sex ratio of 1.8. This result corroborates that of Diedon H [<xref ref-type="bibr" rid="scirp.117124-ref13">13</xref>] who found 67.1%. However, we did not find any significant relationship between gender and the occurrence of tuberculosis in the literature. The majority of patients (47.3%) came from a poor background (<xref ref-type="table" rid="table1">Table 1</xref>). This result is similar to that reported by Barchiche N et al. [<xref ref-type="bibr" rid="scirp.117124-ref14">14</xref>] who found 48%. Indeed, low income and especially precariousness favour the occurrence of tuberculosis infection. The BCG scar was found in 75.8% of patients (<xref ref-type="table" rid="table2">Table 2</xref>), a considerably higher result than those reported by Soumana A [<xref ref-type="bibr" rid="scirp.117124-ref12">12</xref>] and Mabiala et al. [<xref ref-type="bibr" rid="scirp.117124-ref15">15</xref>] who found 65.52% and 60.7% respectively. However, BCG vaccination does not fully protect against tuberculosis disease, but rather protects the child against severe forms (meningitis and miliary tuberculosis). The close contact of children with a bacilloscopy-positive adult with tuberculosis is a factor that favours the occurrence of tuberculosis infection in these children. In our study, tuberculosis contact was found in 23.08% of cases and the contaminators were direct parents in 76.19% (<xref ref-type="table" rid="table3">Table 3</xref>). Our result is comparable to that of Soumana A [<xref ref-type="bibr" rid="scirp.117124-ref12">12</xref>] who found 27.59% of whom 87.50% were direct relatives. De Pontual et al. [<xref ref-type="bibr" rid="scirp.117124-ref16">16</xref>] reported 83% of tuberculosis infections. The clinical manifestations encountered were numerous and varied due to the clinical polymorphism of tuberculosis in children. In our study, the chronic cough was found in 84.6% of cases (<xref ref-type="table" rid="table4">Table 4</xref>). Diedon H A [<xref ref-type="bibr" rid="scirp.117124-ref13">13</xref>] found a higher proportion (94.8%). However, for Soumana A [<xref ref-type="bibr" rid="scirp.117124-ref12">12</xref>], cough represented only 16%. These results show us that cough is one of the main signs of bacillary impregnation in children with pulmonary tuberculosis. Undernutrition was found in 24.17% of patients (<xref ref-type="table" rid="table4">Table 4</xref>). Soumana A [<xref ref-type="bibr" rid="scirp.117124-ref12">12</xref>] and Mabiala et al. [<xref ref-type="bibr" rid="scirp.117124-ref15">15</xref>] reported higher results, respectively 55% and 75.4%. This undernutrition is the consequence of tuberculosis, which leads to anorexia and intestinal malabsorption in patients. As in many other countries, the diagnosis of tuberculosis in children in Mali is not always easy due to the limited means of diagnosis and the paucibacillary nature of tuberculosis in children. The most common radiological findings were alveolar condensations (50.5% of cases), followed by mediastinal adenopathies (12.08%) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Other pulmonary lesions such as caverns (4.39%), nodules (6.6%), miliaries (1.1%), and pleurisy (9.89%) were rarely encountered. Mabiala et al. [<xref ref-type="bibr" rid="scirp.117124-ref15">15</xref>] found 40.2% mediastinal adenopathy and 2.6% cavern. In another study, Mabiala et al. [<xref ref-type="bibr" rid="scirp.117124-ref17">17</xref>] found 29.5%, 11.4%, and 13.11% of mediastinal adenopathy, pleurisy, and miliary. Segbedji K et al. [<xref ref-type="bibr" rid="scirp.117124-ref11">11</xref>] had 10.8% and 5.4% of miliary and pleurisy respectively. This shows the great diversity and especially the rarity of pathological radiological images likely to make the diagnosis of pulmonary tuberculosis in children. Intra Dermo-Reaction (IDR) was positive in only 10.99% of the children, the largest diameter was 25 mm. Our result could be explained by the frequency of HIV infection and malnutrition. Barchiche N et al. [<xref ref-type="bibr" rid="scirp.117124-ref14">14</xref>] in their study (aspects of tuberculosis in</p><p>children in 153 cases) reported 50.55% positive IDR while Folquet et al. [<xref ref-type="bibr" rid="scirp.117124-ref18">18</xref>] and Soumana A [<xref ref-type="bibr" rid="scirp.117124-ref12">12</xref>] had higher proportions with 73.50% and 85.71% respectively. However, it is also important to note that a negative TST does not eliminate the diagnosis of TB. Microscopy was positive in 24 patients (26.4%) (<xref ref-type="table" rid="table5">Table 5</xref>). Segbedji K et al. [<xref ref-type="bibr" rid="scirp.117124-ref11">11</xref>] found a higher result than ours with 39.19% positive microscopy. However, our result is higher than that of Khatib S et al. [<xref ref-type="bibr" rid="scirp.117124-ref19">19</xref>] who reported 10%. Gene Xpert MTB/RIF was positive in 17 children (18.7%) and culture in 25 children (<xref ref-type="table" rid="table5">Table 5</xref>). Zar H et al. [<xref ref-type="bibr" rid="scirp.117124-ref20">20</xref>] reported 15.5% culture positive, 6% microscopy positive, and 12.8% Gene Xpert positive. Overall, these low rates demonstrate the difficulty of confirming the diagnosis of TB in children. So, at the end of the above investigations, 44 patients were confirmed positive for tuberculosis out of 91 suspected cases. Tuberculosis (TB)/HIV co-infection was found in 46.4% of patients (<xref ref-type="table" rid="table6">Table 6</xref>) with an OR(CI) of 1.11 (0.437 - 2.827) (P = 0.8249). Thus, we could say that there is not a statistically significant relationship between TB and HIV but HIV immunosuppression is a factor increasing the risk of progression to TB disease. Furthermore, HIV infection should always be investigated in cases of TB and vice versa. The frequency of co-infection was higher than ours in Mabiala et al. [<xref ref-type="bibr" rid="scirp.117124-ref15">15</xref>] with 65.5% of cases and Segbedji K et al. [<xref ref-type="bibr" rid="scirp.117124-ref11">11</xref>] in Togo reported 15% of co-infection. The diagnosis of TB was confirmed in only 48.4% of suspected cases (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Pulmonary tuberculosis was the overwhelming majority with 93.2% of the confirmed cases (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The predominance of this location is usually reported by many other authors [<xref ref-type="bibr" rid="scirp.117124-ref21">21</xref>]. For example, Loufoua et al. [<xref ref-type="bibr" rid="scirp.117124-ref22">22</xref>], Cardenat et al. [<xref ref-type="bibr" rid="scirp.117124-ref23">23</xref>], and Koueta et al. [<xref ref-type="bibr" rid="scirp.117124-ref24">24</xref>] reported 70.8% in Gabon, and 77.24% in C&#244;te d’Ivoire and 86.4% in Burkina Faso respectively. The extrapulmonary form represented 6.8% (lymph nodes in 4.5% and osteoarticular in 2.3%). Furthermore, Barchiche N et al. [<xref ref-type="bibr" rid="scirp.117124-ref14">14</xref>] reported 35.71% of lymph node localisation. Antituberculosis treatment was used in 38 patients (86.4%) and the 2RHZE/4RH (2 months of treatment with Rifampicin + Isoniazid + Pyrazinamide + Ethambutol, followed by 4 months of treatment with Rifampicin + Isoniazid) regimen was used in 31 patients (81.6%) (<xref ref-type="table" rid="table7">Table 7</xref>). This result is superior to those of Morba A [<xref ref-type="bibr" rid="scirp.117124-ref9">9</xref>] and Ciss&#233; A et al. [<xref ref-type="bibr" rid="scirp.117124-ref10">10</xref>] who respectively used the same regimen in 58.8% and 56.7% of their cohorts. The therapeutic success rate (65.9%) was lower than those reported by Morba A [<xref ref-type="bibr" rid="scirp.117124-ref9">9</xref>] and Segbedji K et al. [<xref ref-type="bibr" rid="scirp.117124-ref11">11</xref>] who found 70.58% and 76% respectively. This result can be explained by a temporary break in the supply of anti-tuberculosis drugs that we observed. The number of patients lost to follow-up was 13.6% and the mortality rate was 18.2%. Among the unconfirmed cases, some were put on anti-tuberculosis treatment and others on Isoniazid preventive treatment. These patients did not want to continue the follow-up to a lack of evidence.</p></sec><sec id="s5"><title>5. Conclusion</title><p>We were able to identify several suspected cases of tuberculosis in the department of paediatrics that previously might have gone unnoticed. As the clinical signs of tuberculosis in children are not always as specific as in adults, further and more rigorous studies are needed for the diagnosis of tuberculosis in children.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Demb&#233;l&#233;, A., Diakit&#233;, A.A., Ciss&#233;, M.E., Diarra, B., Ma&#239;ga, B., Sanou, I., Togo, P., Doumbia, A.K., Coulibaly, O., Sacko, K., Konat&#233;, D., Diall, H., Sidib&#233;, L.N., D&#233;goga, B., Diakit&#233;, F.L., Demb&#233;l&#233;, G., Dicko, F., Sylla, M. and Togo, B. (2022) Tuberculosis in Children: Epidemio-Clinical Aspects in the Paediatric Department of the Gabriel Tour&#233; University Hospital Center. Open Journal of Pediatrics, 12, 376-388. https://doi.org/10.4236/ojped.2022.122042</p></sec></body><back><ref-list><title>References</title><ref id="scirp.117124-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Diallo, S., Dao, S., Dembélé, J.P., Toloba, Y., Kassambara, H., Berthe, M. and Bougoudogo, F. (2008) Aspects épidémiologiques de la tuberculose pulmonaire à bacilloscopie positive au Mali pendant la décennie 1995-2004. Mali Médical, 23, 25-29.</mixed-citation></ref><ref id="scirp.117124-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aubry</surname><given-names> P. </given-names></name>,<etal>et al</etal>. (<year>2014</year>)<article-title>Actualités sur la tuberculose</article-title><source> Bulletin de la Société de Pathologie Exotique</source><volume> 107</volume>,<fpage> 127</fpage>-<lpage>128</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.117124-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Souidi, L. (2014) Prévalence de la tuberculose pulmonaire à Oujda-Anggad entre 2008 et 2012. Thèse de Doctorat en Pharmacie, Université Mohammed V de Rabat, Rabat.</mixed-citation></ref><ref id="scirp.117124-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2018) Rapport sur la lutte contre la tuberculose dans le monde 2018: Résumé d’orientation. http://www.who.int/fr</mixed-citation></ref><ref id="scirp.117124-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">OMS Afrique (2018) Tuberculose. Regional Office for Africa. http://afro.who.int</mixed-citation></ref><ref id="scirp.117124-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">PNLT Cote d’Ivoire (2016) Plan stratégique national de lutte contre la tuberculose 2016-2020. Ministre de la Santé et de la Lutte contre le Sida.</mixed-citation></ref><ref id="scirp.117124-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Aubry, P. and Gaüzère, B. (2018). Tuberculose: Actualité 2018. Centre René Labusquière, Institut de Médecine Tropicale, Université de Bordeaux, Bordeaux.  
http://www.medecinetropicale.com</mixed-citation></ref><ref id="scirp.117124-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">PNLT au Mali (2018) Rapport Annuel 2018. Division prévention et lutte contre la maladie.</mixed-citation></ref><ref id="scirp.117124-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Morba, A. (2011) La tuberculose (pulmonaire et extra-pulmonaire) dans le service de pédiatrie CHU-GT à propos de 17 cas. Thèse de Médecine FMPOS Bamako, Bamako, 58 p.</mixed-citation></ref><ref id="scirp.117124-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cisse, A. (2009) Etude Epidémiologie et Clinique de la Tuberculose chez les Enfants de 0-15 dans les six centres de santé de référence de Bamako. Thèse de Médecine, Université de Bamako, Bamako, 71 p.</mixed-citation></ref><ref id="scirp.117124-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Segbedji, K., Djadou, K., Tchagbele, O., Kpegouni, M., Bessi Kama, L., Azoumah, K. and Agbere, A. (2016) Tuberculose de l’enfant au Togo: Aspects épidémiologiques, diagnostiques, thérapeutiques et évolutifs. Médecine et Santé Tropicales, 26, 318-322. https://doi.org/10.1684/mst.2016.0593</mixed-citation></ref><ref id="scirp.117124-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Soumana, A., Kamaye, M., Ngoumboute, I., Dima, H., Daouda, B. and Guéro, T. (2016) La tuberculose chez l’enfant: à propos de 29 cas colliges dans deux hopitaux de niamey et au centre national antituberculeux. Mali Médical, 31, 1-8.</mixed-citation></ref><ref id="scirp.117124-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Diedon, H. (2002) Tuberculose de l’enfant et co&amp;iuml;nfection à HIV au CNLAT et au CHNYO de Ouagadougou. Thèse de Médecine, Université de Ouagadougou, Ouagadougou.</mixed-citation></ref><ref id="scirp.117124-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Barchiche, N.A., Berkani, A., Chernai, M., Aitabdeslam, S. and Meguenni, W. (2010) Aspects de la tuberculose chez l’enfant à propos de 153 cas. Pathologie Biologie, 58, e33-e38. https://doi.org/10.1016/j.patbio.2009.07.007</mixed-citation></ref><ref id="scirp.117124-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mabiala-Babela, J.R., Makosso, E. and Senga, P. (2007) Etude rétrospective de 61 cas de tuberculose multifocale chez l’enfant à Brazzaville, Congo. Médecine Tropicale, 67, 41-44.</mixed-citation></ref><ref id="scirp.117124-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">De Pontual, L., Hollebecque, V., Bessa, Z. and Muller, M.H. (2004) Enquête sur la tuberculose pédiatrique en Seine Saint Denis: Les moyens qui ont permis le contr&amp;ocirc;le de la recrudescence. The International Journal of Tuberculosis and Lung Disease, 8, 976-981.</mixed-citation></ref><ref id="scirp.117124-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mabiala-Balela, J.R., Makosso, E. and Senga, P. (2006) Aspects radiologique de la tuberculose pulmonaire chez l’enfant congolais: Influence de l’infection à VIH. Médecine Tropicale, 66, 255-259.</mixed-citation></ref><ref id="scirp.117124-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Folquet, A.M., Gauze, J.C., Kouakou, K.C., Dainguy, M.E., Diomande, D., et al. (2006) Miliaire tuberculeuse chez l’enfant. A propos 89 cas colligés au Centre anti-tuberculeux d’Adjamé. Mali Médical, 21, 15-18.</mixed-citation></ref><ref id="scirp.117124-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Khatib, S. and Bourkadi, J. (2016) Tuberculose de l’enfant: à propos de 285 cas. Revue des Maladies Respiratoires, 33, A161. 
https://doi.org/10.1016/j.rmr.2015.10.319</mixed-citation></ref><ref id="scirp.117124-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zar, H.J. (2011) Diagnostic de la tuberculose pulmonaire chez l’enfant: Enfin du nouveau! Société de Pneumologie de Langue Franaise, Cape Town.</mixed-citation></ref><ref id="scirp.117124-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Nelliyanil, M., Sharada, M.P., Joseph, N., et al. (2012) A Study of the Socio-Demographic Profile and Treatment Outcome of Paediatric Tuberculosis Patients in Bangalore Mahanagar Palike Area. Indian Journal of Tuberculosis, 59, 207-213.</mixed-citation></ref><ref id="scirp.117124-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Loufoua-Lemay, A.M., Youndouka, J.M., Pambou, B. and Nzingoula, S. (2008) La tuberculose chez l’enfant au CHU de Brazzaville de 1995 à 2003. Bulletin de la Société de Pathologie Exotique, 101, 303-307.</mixed-citation></ref><ref id="scirp.117124-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Cardenat, M., Horo, K., Amon Tanoh Dick, F., et al. (2014) La tuberculose à Abidjan: Comparaison entre l’enfant et l’adulte. Médecine et Santé Tropicales, 24, 289-293.  
https://doi.org/10.1684/mst.2014.0362</mixed-citation></ref><ref id="scirp.117124-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Koueta, F., Ouedraogo, G., Dao, L., Neboua, D. and Ye, D. (2011) Tuberculose chez les enfants infectés par le VIH suivis au CHU Pediatrique Charles De Gaulle à Ouagadougou. Mali Médical, 26, 44-49.</mixed-citation></ref></ref-list></back></article>